Alcohol and Metabolic-associated Fatty Liver Disease

被引:10
|
作者
Sun, Fu-Rong [1 ]
Wang, Bing-Yuan [1 ]
机构
[1] China Med Univ, Dept Elderly Gastroenterol, First Hosp, Shenyang, Liaoning, Peoples R China
关键词
Alcohol; Metabolic-associated fatty liver disease; Obesity; Insulin resistance; Hypertension; CARDIOVASCULAR RISK-FACTORS; HIGH-DENSITY-LIPOPROTEINS; KOREA NATIONAL-HEALTH; BODY-MASS INDEX; BLOOD-PRESSURE; INSULIN SENSITIVITY; RED WINE; BEVERAGE CONSUMPTION; CHINESE POPULATION; ACID METABOLISM;
D O I
10.14218/JCTH.2021.00173
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The diagnosis of metabolic-associated fatty liver disease is based on the detection of liver steatosis together with the presence of metabolic dysfunction. According to this new defi-nition, the diagnosis of metabolic-associated fatty liver disease is independent of the amount of alcohol consumed. Actually, alcohol and its metabolites have various effects on metabolic-associated abnormalities during the process of alcohol me-tabolism. Studies have shown improved metabolic function in light to moderate alcohol drinkers. There are several studies focusing on the role of light to moderate alcohol intake on metabolic dysfunction. However, the results from studies are diverse, and the conclusions are often controversial. This re-view systematically discusses the effects of alcohol consump-tion, focusing on light to moderate alcohol consumption, on obesity, lipid and glucose metabolism, and blood pressure. Citation of this article: Sun FR, Wang BY. Alcohol and metabolic-associated fatty liver disease. J Clin Transl Hepa-tol 2021. doi: 10.14218/JCTH.2021.00173.
引用
收藏
页码:719 / 730
页数:12
相关论文
共 50 条
  • [41] The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease
    Bayoumi, Ali
    Gronbaek, Henning
    George, Jacob
    Eslam, Mohammed
    TRENDS IN GENETICS, 2020, 36 (06) : 429 - 441
  • [42] Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
    Badmus, Olufunto O.
    Hinds, Terry D.
    Stec, David E.
    CURRENT HYPERTENSION REPORTS, 2023, 25 (08) : 151 - 162
  • [43] Diagnostic indicators and lifestyle interventions of metabolic-associated fatty liver disease
    Chen, Tianzhu
    Qin, Xiang
    Jiang, Jianping
    He, Beihui
    FRONTIERS IN NUTRITION, 2024, 11
  • [44] Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease
    Boldys, Aleksandra
    Buldak, Lukasz
    Maliglowka, Mateusz
    Surma, Stanislaw
    Okopien, Boguslaw
    MEDICINA-LITHUANIA, 2023, 59 (10):
  • [45] The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease
    Seo, Ji-Yeon
    Bae, Jung-Ho
    Kwak, Min-Sun
    Yang, Jong-In
    Chung, Su-Jin
    Yim, Jeong-Yoon
    Lim, Seon-Hee
    Chung, Goh-Eun
    BIOMEDICINES, 2021, 9 (10)
  • [46] Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease
    Bae, Jaehyun
    Lee, Byung-Wan
    BIOMOLECULES, 2023, 13 (10)
  • [47] Metabolic-associated fatty liver disease in children and adolescents: Mexican experience
    Mendez-Sanchez, Nahum
    Diaz-Orozco, Luis E.
    Santamaria-Arza, Claudia
    Orozco-Morales, Jose A.
    Medina-Bravo, Patricia G.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 986 - 986
  • [48] Metabolic-Associated Fatty Liver Disease: A Disastrous Human Health Challenge
    Fouda, Sherouk
    Pappachan, Joseph M.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03)
  • [49] Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?
    Younossi, Zobair M.
    Paik, James M.
    Al Shabeeb, Reem
    Golabi, Pegah
    Younossi, Issah
    Henry, Linda
    HEPATOLOGY, 2022, 76 (05) : 1423 - 1437
  • [50] Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease
    Zhang, Ni
    Tian, Xinchen
    Yan, Tinghao
    Wang, Haochen
    Zhang, Dengtian
    Lin, Cong
    Liu, Qingbin
    Jiang, Shulong
    FRONTIERS IN IMMUNOLOGY, 2023, 14